Can treatment with adalimumab be stopped once it is used?

Adalimumab(Adalimumab), as a highly effective immunomodulatory drug, is widely used in the treatment of chronic autoimmune diseases such as rheumatoid arthritis, psoriasis, and Crohn's disease. Many patients have significantly relieved their symptoms after using this drug, so questions often arise: Once such drugs are started, can they not be stopped? From a professional perspective, adalimumab is not "unstoppable", but whether to stop the drug must be decided based on the specific condition, treatment goals and the doctor's comprehensive judgment, and cannot be interrupted at will.

Autoimmune diseases are usually chronic and recurring diseases. The fluctuation of the condition is affected by a variety of factors. The abnormal activation process of the immune system will not be permanently terminated by short-term medication. Adalimumab interrupts the inflammatory response chain by inhibiting TNF-α, thereby relieving symptoms and preventing disease progression. Once the medication is stopped rashly, the levels of inflammatory factors in the body may rise rapidly, leading to a rebound in the condition, aggravation of symptoms, and even serious complications.

However, this does not mean that all patients need to take this drug for life. In some patients with stable disease and clinical remission, doctors may evaluate the feasibility of discontinuing or reducing the drug. Generally, comprehensive judgment including inflammatory index detection, imaging assessment, and quality of life assessment is required before a gradual discontinuation plan can be formulated. Some studies suggest that some patients who are diagnosed early and receive active treatment have the opportunity to gradually reduce or even completely stop taking their medications after achieving sustained remission, but this must be done under professional supervision.

In addition, some patients need to consider drug discontinuation due to side effects or financial reasons. At this time, they should not stop taking the drug on their own, but should communicate with their attending doctor to find alternatives or adjust treatment strategies. For example, switching to other biologics or combining immunosuppressants to control the disease can prevent recurrence of the disease after discontinuation of adalimumab.

Reference materials:https://www.drugs.com/adalimumab.html